wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36652462-01FBCAB3-3AAD-41ED-A475-5FDBC298A77E
Q36652462-01FBCAB3-3AAD-41ED-A475-5FDBC298A77E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36652462-01FBCAB3-3AAD-41ED-A475-5FDBC298A77E
One-Year Safety of Olodaterol Once Daily via Respimat® in Patients with GOLD 2-4 Chronic Obstructive Pulmonary Disease: Results of a Pre-Specified Pooled Analysis.
P2860
Q36652462-01FBCAB3-3AAD-41ED-A475-5FDBC298A77E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36652462-01FBCAB3-3AAD-41ED-A475-5FDBC298A77E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
baca0b308aa5ca07f9d6609faf109a14c401cd7b
P2860
The 24-h FEV1 time profile of olodaterol once daily via Respimat® and formoterol twice daily via Aerolizer® in patients with GOLD 2-4 COPD: results from two 6-week crossover studies.